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ABSTRACT 
 
Systematic Comparison of Parameter Estimation Approaches Using the Generalized-
growth Model for Prediction of Epidemic Outbreaks 
 
By 
 
Yiseul Lee, Kimberlyn Roosa, Amna Tariq, and Gerardo Chowell 
 
May 7th, 2019 
 
 
 
 
Background- Many different mathematical models are used to assess and predict the outbreaks. 
The model is selected by the characteristics of the outbreaks. Here, we utilize the generalized 
growth model (GGM), one of the simplest mathematical models, with the real outbreaks to 
compare two parameter estimation methods.  
Materials and Methods- 25 outbreaks are used to analyze. We use GGM with the ascending 
phase of each outbreak and estimated the r and p parameters with both the least square (LSQ) 
and maximum likelihood estimation (MLE) methods. For both parameter estimation methods, 
we conduct the parametric bootstrap method to construct the confidence interval of parameters. 
We compare the two estimation methods by the RMSE, Anscombe residual, and prediction 
coverage.    
Results- The result show that the most outbreaks have similar r and p parameters, RMSE, 
Anscombe, and prediction coverage for LSQ and MLE. Although Anscombe values for LSQ are 
higher than the values for MLE, the different between results of the two methods are minimal for 
the most outbreaks. 
Conclusion- The study is shown that LSQ and MLE do not result in different values of the 
parameter estimation, RMSE, Anscombe, and prediction coverage with GGM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCHOOL BOARD PERCEPTIONS OF RESPONSIBILITIES FOR 
CHILDHOOD OVERWEIGHT 
 
 
by 
 
JOAN Q. STUDENT 
 
B.A., GEORGIA STATE UNIVERSITY 
 
(List other degrees awarded in the same format) 
 
 
 
 
A Thesis Submitted to the Graduate Faculty 
of Georgia State University in Partial Fulfillment 
of the 
Requirements for the Degree 
 
MASTER OF PUBLIC HEALTH 
 
 
ATLANTA, GEORGIA 
30303 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPROVAL PAGE  
 
 
SCHOOL BOARD PERCEPTIONS OF RESPONSIBILITIES FOR 
CHILDHOOD OVERWEIGHT 
 
 
by  
 
 JOAN Q. STUDENT 
 
 
 
 
 
 
Approved:  
 
 
 
 
__Dr. Gerardo Chowell____  
Committee Chair  
 
 
 
__Dr. Ruiyan Luo_____  
Committee Member  
 
 
 
__ May 7, 2019_______  
Date  
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgments  
 
(This page is optional.) 
Author’s Statement Page  
 
 
In presenting this thesis as a partial fulfillment of the requirements for an advanced 
degree from Georgia State University, I agree that the Library of the University shall make it 
available for inspection and circulation in accordance with its regulations governing materials of 
this type. I agree that permission to quote from, to copy from, or to publish this thesis may be 
granted by the author or, in his/her absence, by the professor under whose direction it was 
written, or in his/her absence, by the Associate Dean, School of Public Health. Such quoting, 
copying, or publishing must be solely for scholarly purposes and will not involve potential 
financial gain. It is understood that any copying from or publication of this dissertation which 
involves potential financial gain will not be allowed without written permission of the author.  
 
___Yiseul Lee_____________ 
Signature of Author 
 
 
 
 
 
 
 
 
 
  
 
TABLE OF CONTENTS 
 
LIST OF TABLES………………………………………………………………………………………………………………...1 
LIST OF FIGURES………………………………………………………………………………………………………………...4 
INTRODUCTION.....................................................................................................................5 
Background………………………………………………………………….………...... 5  
Review of the literature………………………………………………………………6 
     Research Questions…………………………………………………………………….6  
 
Data and methods………………….......................................................................... 6  
     2.1 Data sources………………………………………………………………………….6  
     2.2 Generalized Growth Model…………………………………………………...7 
     2.3 Parameter Estimation Method..................................................7 
     2.4 Root Mean Square Error and Anscombe residual.....................8 
     2.5 Performance..............................................................................9 
 
 
 RESULTS..............................................................................................................................9  
     3.1 r and p parameter estimation………………………..………..……………..12 
     3.2 Root Mean Square Error………………………………………………………...12 
     3.3 Anscombe residual......................................................................13 
     3.4 Prediction interval coverage.......................................................13 
 
 
 DISCUSSION AND CONCLUSION.......................................................................................... 15                      
     4.1 Discussion of Research Questions...................................................15  
     4.2 Study Strengths and Limitations......................................................16 
     4.3 Conclusions………………………………………………………………………………….17 
 
REFERENCES...........................................................................................................................18 
APPENDIX………………………………………………………………………………………………….………………………...i 
 
 
 
1 
 
List of Tables 
 
Table 1 Result of r and p parameters with 95% CI, RMSE, Anscombe residual, prediction coverage, and the length of ascending 
phase by LSQ for each outbreak.  
 
LSQ r (95% CI) p (95% CI) RMSE Anscombe  
Prediction 
interval 
coverage 
(%) 
length of 
ascending 
phase 
Zika (Antioquia, 2016) 0.97 (0.69, 1.3) 0.57 (0.5, 0.65) 4.6547 26.1701 96.67 30 /104 days 
Zika (Antioquia, 2016) 1.6 (0.71, 2.9) 0.43 (0.24, 0.67) 3.7148 16.3014 100.00 15/104 days 
Zika (Antioquia, 2016) 1.4 (0.78, 2.3) 0.47 (0.31, 0.65) 3.3072 16.4055 100.00 16/104 days 
FMD (UK,2001-120days) 0.56 (0.37, 0.78) 0.7 (0.6, 0.82) 3.2558 38.0777 96.00 25/229 days 
Ebola (Tonkolili, 2014) 0.19 (0.079, 0.42) 0.77 (0.51, 1) 4.7434 8.2564 83.33 6/69 weeks 
Cholera (Aalborg,1853) 0.55 (0.36, 0.8) 0.78 (0.69, 0.88) 7.8581 36.7622 90.00 20/108 days 
Ebola (Bo, 2014) 0.13 (0.083, 0.2) 0.81 (0.69, 0.94) 9.6592 27.4445 80.00 10/67 weeks 
Ebola (Bombali, 2014) 0.081 (0.064, 0.13) 0.95 (0.81, 1) 4.0774 17.0611 87.50 8/64 weeks 
Ebola (Bomi, 2014) 1.2 (0.46, 2) 0.13 (0, 0.38) 5.9372 19.6657 75.00 8/66 weeks 
Ebola (Congo, 1976) 1.3 (0.65, 2.1) 0.44 (0.28, 0.63) 3.6671 19.5928 100.00 20/52 days 
Ebola (Grand Bassa, 2014) 0.42 (0.15, 0.97) 0.34 (0.058, 0.63) 3.5119 7.6974 100.00 9/64 weeks 
Ebola (Gueckedou, 2014) 0.14 (0.04, 0.32) 0.65 (0.37, 1) 3.8494 18.0131 90.91 11/90 weeks 
Ebola (Kenema, 2014) 0.57 (0.33, 0.85) 0.47 (0.34, 0.6) 9.1378 17.5478 87.50 8/70 weeks 
Ebola (Margibi, 2014) 0.2 (0.14, 0.26) 0.75 (0.67, 0.84) 15.7639 67.8336 50.00 10/68 weeks 
Ebola (Margibi, 2014) 0.21 (0.16, 0.28) 0.72 (0.65, 0.8) 17.9671 73.2763 54.55 11/68 weeks 
Ebola (Montserrado, 2014) 0.088 (0.081, 0.11) 0.98 (0.9, 1) 9.3648 47.311 50.00 10/71 weeks 
Ebola (Port Loko, 2014) 0.57 (0.36, 0.83) 0.5 (0.4, 0.61) 8.8882 2.8635 100.00 8/64 weeks 
Ebola (Uganda, 2000) 0.34 (0.21, 0.53) 0.67 (0.52, 0.82) 5.1478 1.9795 100.00 6/18 weeks 
Ebola (Western Area Rural, 2014) 0.32 (0.22, 0.44) 0.62 (0.53, 0.71) 7.064 12.5064 90.00 10/63 weeks 
Ebola (Western Area Urban, 2014) 0.5 (0.32, 0.73) 0.53 (0.44, 0.63) 7.1063 12.1428 90.00 10/62 weeks 
FMD (Uruguay, 2001) 9.2 (7.5, 11) 0.52 (0.49, 0.55) 78.1816 163.4178 36.36 11/27 days 
HIV-AIDS (Japan, 1985-2012) 0.1 (0.097, 0.11) 0.5 (0.49, 0.51) 574.6561 784.7399 18.18 11/21 years 
HIV-AIDS (NYC, 1982-2002) 2.7 (1.6, 4.4) 0.47 (0.33, 0.6) 6.1496 22.2194 81.81 11/21 years 
Measles (London, 1948) 1.7 (1.3, 2.2) 0.51 (0.48, 0.55) 85.8138 135.7374 44.44 9/40 weeks 
Pandemic influenza (San Fran, 1918) 0.29 (0.28, 0.34) 0.99 (0.95, 1) 8.4321 57.9749 60.00 20/63 days 
Plague (Bombay, 1905-06) 0.12 (0.074, 0.17) 0.88 (0.79, 0.98) 6.5659 5.30811 100.00 9/41 weeks 
Plague (Madagascar-wave2, 2017) 0.12 (0.072, 0.18)  0.81 (0.71, 0.94) 3.451 8.1155 100.00 11/50 weeks 
Smallpox (Khulna, Bangladesh, 1972) 0.16 (0.11, 0.21) 0.85 (0.78, 0.93) 15.2023 17.3744 77.78 9/13 weeks 
 
Table 2 Result of r and p parameters with 95% CI, RMSE, Anscombe residual, prediction coverage, and the length of ascending 
phase by MLE for each outbreak.  
 
Outbreaks r (95% CI) p (95% CI) RMSE Anscombe  
Prediction 
interval 
coverage 
(%) 
length of 
ascending 
phase 
Zika (Antioquia, 2016) 1.1 (0.82, 1.4) 0.55 (0.48, 0.61) 4.9396 25.6333 100.00 30 /104 days 
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Zika (Antioquia, 2016) 1.3 (0.75, 2.2) 0.49 (0.32, 0.65) 2.9777 15.5843 100.00 15/104 days 
Zika (Antioquia, 2016) 1.2 (0.73, 2.1) 0.51 (0.34, 0.68) 3.6486 16.0586 100.00 16/104 days 
FMD (UK,2001-120days) 0.5 (0.36, 0.67) 0.73 (0.64, 0.83) 4.005 37.2877 96.00 25/229 days 
Ebola (Tonkolili, 2014) 0.15 (0.077, 0.32) 0.82 (0.58, 1) 6.5574 8.0175 83.33 6/69 weeks 
Cholera (Aalborg,1853) 0.49 (0.34, 0.67) 0.81 (0.73, 0.89) 6.2008 36.4364 95.00 20/108 days 
Ebola (Bo, 2014) 0.13 (0.089, 0.18) 0.81 (0.71, 0.92) 9.7877 27.4529 80.00 10/67 weeks 
Ebola (Bombali, 2014) 0.075(0.063, 0.12) 0.97 (0.82, 1) 3.8406 16.0682 87.50 8/64 weeks 
Ebola (Bomi, 2014) 1.1 (0.47, 2) 0.15 (0, 0.38) 6.8829 19.6677 75.00 8/66 weeks 
Ebola (Congo, 1976) 1.1 (0.67, 1.8) 0.48, (0.32, 0.62) 3.4132 19.3494 95.00 20/52 days 
Ebola (Grand Bassa, 2014) 0.35 (0.14, 0.72) 0.4 (0.1, 0.68) 3.7712 7.4662 100.00 9/64 weeks 
Ebola (Gueckedou, 2014) 0.12 (0.042, 0.27) 0.69 (0.4, 0.97) 4 17.9151 90.91 11/90 weeks 
Ebola (Kenema, 2014) 0.53 (0.34, 0.78) 0.49 (0.38, 0.6) 5.4314 17.3496 87.50 8/70 weeks 
Ebola (Margibi, 2014) 0.13 90.11, 0.17) 0.86 (0.79, 0.93) 21.5708 57.1537 60.00 10/68 weeks 
Ebola (Margibi, 2014) 0.15 (0.13, 0.19) 0.84 (0.75, 0.87) 16.8415 63.2808 54.55 11/68 weeks 
Ebola (Montserrado, 2014) 0.15 (0.12, 0.2) 0.8 (0.72, 0.88) 9.7005 29.4463 70.00 10/71 weeks 
Ebola (Port Loko, 2014) 0.55 (0.37, 0.8) 0.51 (0.41, 0.6) 4.8348 2.8323 100.00 8/64 weeks 
Ebola (Uganda, 2000) 0.4 (0.25, 0.59) 0.62 (0.49, 0.76) 8.1138 1.5743 100.00 6/18 weeks 
Ebola (Western Area Rural, 2014) 0.32 (0.24, 0.43) 0.62 (0.54, 0.69) 8.3666 12.5039 100.00 10/63 weeks 
Ebola (Western Area Urban, 2014) 0.53 (0.36, 0.74) 0.52 (0.44, 0.6) 6.9785 12.0879 90.00 10/62 weeks 
FMD (Uruguay, 2001) 8.2 (6.7, 9.9) 0.54 (0.51, 0.57) 62.4915 161.757 36.36 11/27 days 
HIV-AIDS (Japan, 1985-2012) 0.081 (0.076, 0.086) 0.53 (0.52, 0.53) 551.8599 725.4638 18.18 11/21 years 
HIV-AIDS (NYC, 1982-2002) 2.3 (1.4, 3.4) 0.51 (0.4, 0.63) 4.5826 21.4924 81.81 11/21 years 
Measles (London, 1948) 2.9 (2.3, 3.6) 0.44 (0.41, 0.47) 67.5681 118.335 33.33 9/40 weeks 
Pandemic influenza (San Fran, 1918) 0.35 (0.3, 0.41) 0.94 (0.91, 0.98) 14.0535 52.5996 70.00 20/63 days 
Plague (Bombay, 1905-06) 0.12 (0.085, 0.17) 0.88 (0.78, 0.98) 4.3205 4.9868 100.00 9/41 weeks 
Plague (Madagascar-wave2, 2017) 0.11 (0.073, 0.15) 0.84 (0.75, 0.93) 6.6332 7.5833 100.00 11/50 weeks 
Smallpox (Khulna, Bangladesh, 1972) 0.14 (0.11, 0.17) 0.87 (0.82, 0.93) 15.8184 16.3525 88.89 9/13 weeks 
 
Table 3 Difference between LSQ and MLE results. (LSQ-MLE) 
 
Difference r  p RMSE 
 
Abs. 
RMSE 
Ansco
mbe  
Abs. 
Anscom
be  
p_cov
erage 
(%) 
Abs. 
value of 
p_cover
age (%) 
length of 
ascending 
phase 
Zika (Antioquia, 2016) -0.13 0.02 -0.2849 
 
0.2849 0.5368 0.5368 -3.33 3.33 30 /104 days 
Zika (Antioquia, 2016) 0.3 -0.06 0.7371 
 
0.7371 0.7171 0.7171 0.00 0.00 15/104 days 
Zika (Antioquia, 2016) 0.2 -0.04 -0.3414 
 
0.3414 0.3469 0.3469 0.00 0.00 16/104 days 
FMD (UK,2001-120days) 0.06 -0.03 -0.7492 
 
0.7492 0.79 0.79 0.00 0.00 25/229 days 
Ebola (Tonkolili, 2014) 0.04 -0.05 -1.814 
 
1.814 0.2389 0.2389 0.00 0.00 6/69 weeks 
Cholera (Aalborg,1853) 0.06 -0.03 1.6573 
 
1.6573 0.3258 0.3258 -5.00 5.00 20/108 days 
Ebola (Bo, 2014) 0 0 -0.1285 
 
0.1285 -0.0084 0.0084 0.00 0.00 10/67 weeks 
Ebola (Bombali, 2014) 0.006 -0.02 0.2368 
 
0.2368 0.9929 0.9929 0.00 0.00 8/64 weeks 
Ebola (Bomi, 2014) 0.1 -0.02 -0.9457 
 
0.9457 -0.002 0.002 0.00 0.00 8/66 weeks 
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Ebola (Congo, 1976) 0.2 -0.04 0.2539 
 
0.2539 0.2434 0.2434 5.00 5.00 20/52 days 
Ebola (Grand Bassa, 
2014) 0.07 -0.06 -0.2593 
 
0.2593 0.2312 0.2312 0.00 0.00 9/64 weeks 
Ebola (Gueckedou, 2014) 0.02 -0.04 -0.1506 
 
0.1506 0.098 0.098 0.00 0.00 11/90 weeks 
Ebola (Kenema, 2014) 0.04 -0.02 3.7064 
 
3.7064 0.1982 0.1982 0.00 0.00 8/70 weeks 
Ebola (Margibi, 2014) 0.07 -0.11 -5.8069 
 
5.8069 10.6799 10.6799 -10.00 10.00 10/68 weeks 
Ebola (Margibi, 2014) 0.06 -0.09 1.1256 
 
1.1256 9.9955 9.9955 0.00 0.00 11/68 weeks 
Ebola (Montserrado, 
2014) 
-
0.062 0.18 -0.3357 
 
0.3357 17.8647 17.8647 -20.00 20.00 10/71 weeks 
Ebola (Port Loko, 2014) 0.02 -0.01 4.0534 
 
4.0534 0.0312 0.0312 0.00 0.00 8/64 weeks 
Ebola (Uganda, 2000) -0.06 0.05 -2.966 
 
2.966 0.4052 0.4052 0.00 0.00 6/18 weeks 
Ebola (Western Area 
Rural, 2014) 0 0 -1.3026 
 
1.3026 0.0025 0.0025 -10.00 10.00 10/63 weeks 
Ebola (Western Area 
Urban, 2014) -0.03 0.01 0.1278 
 
0.1278 0.0549 0.0549 0.00 0.00 10/62 weeks 
FMD (Uruguay, 2001) 1 -0.02 15.6901 
 
15.6901 1.6608 1.6608 0.00 0.00 11/27 days 
HIV-AIDS (Japan, 1985-
2012) 0.019 -0.03 22.7962 
 
22.7962 59.2761 59.2761 0.00 0.00 11/21 years 
HIV-AIDS (NYC, 1982-
2002) 0.4 -0.04 1.567 
 
1.567 0.727 0.727 0.00 0.00 11/21 years 
Measles (London, 1948) -1.2 0.07 18.2457 
 
18.2457 17.4024 17.4024 11.11 11.11 9/40 weeks 
Pandemic influenza (San 
Fran, 1918) -0.06 0.05 -5.6214 
 
5.6214 5.3753 5.3753 -10.00 10.00 20/63 days 
Plague (Bombay, 1905-
06) 0 0 2.2454 
 
2.2454 0.32131 0.32131 0.00 0.00 9/41 weeks 
Plague (Madagascar-
wave2, 2017) 0.01 -0.03 -3.1822 
 
3.1822 0.5322 0.5322 0.00 0.00 11/50 weeks 
Smallpox (Khulna, 
Bangladesh, 1972) 0.02 -0.02 -0.6161 
 
0.6161 1.0219 1.0219 -11.11 11.11 9/13 weeks 
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Figure1-1. r error bars. For each outbreak, the graphs showed the mean and 95% confidential interval of 
r parameter by LSQ and MLE methods. 
 
Figure1-2. p error bars. For each outbreak, the graphs showed the mean and 95% confidential interval of 
p parameter by LSQ and MLE methods. 
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Abstract 
 
Background- Many different mathematical models are used to assess and predict the outbreaks. 
The model is selected by the characteristics of the outbreaks. Here, we utilize the generalized 
growth model (GGM), one of the simplest mathematical models, with the real outbreaks to 
compare two parameter estimation methods.  
Materials and Methods- 25 outbreaks are used to analyze. We use GGM with the ascending 
phase of each outbreak and estimated the r and p parameters with both the least square (LSQ) 
and maximum likelihood estimation (MLE) methods. For both parameter estimation methods, 
we conduct the parametric bootstrap method to construct the confidence interval of parameters. 
We compare the two estimation methods by the RMSE, Anscombe residual, and prediction 
coverage.    
Results- The result show that the most outbreaks have similar r and p parameters, RMSE, 
Anscombe, and prediction coverage for LSQ and MLE. Although Anscombe values for LSQ are 
higher than the values for MLE, the different between results of the two methods are minimal for 
the most outbreaks. 
Conclusion- The study is shown that LSQ and MLE do not result in different values of the 
parameter estimation, RMSE, Anscombe, and prediction coverage with GGM. 
 
Keywords: parameter estimation; generalized growth model; least square estimation, 
maximum likelihood estimation; epidemiological models 
 
 
1. Introduction 
 
Mathematical models are utilized in infectious disease epidemiology to assess, investigate and 
forecast epidemic outbreaks and understand the underlying mechanisms of disease transmission. 
These mathematical model frameworks also help us understand the epidemic control strategies. 
Various mathematical models are used to investigate epidemic outbreaks, including GGM and 
generalized logistic model (GLM), with each model defined by the characteristics of the 
outbreak. One of the defining outbreak characteristics is the epidemic growth pattern. Epidemic 
growth patterns vary substantially depending on distinctive features of the outbreaks. Even 
within the same type of disease, outbreak patterns can differ, as can be observed with influenza 
virus disease (1). Many infectious disease studies, including studies on the influenza virus 
epidemics, begin with the assumption of an exponential epidemic growth pattern. As has been 
observed historically, influenza outbreaks tend to follow an exponential growth pattern. The 
virus spreads quickly via coughing and droplet spread through air and exhibits a low fatality rate 
6 
 
(0.9%); however, the fatality rate could vary depending on the genotype of the influenza virus 
circulating in the air (2). The exponential growth assumption is not always valid, as infectious 
diseases have other distinct features such as disease transmission methods and incubation period, 
which influence the epidemic disease growth pattern.  For example, Ebola is a viral disease like 
influenza, but it spreads via close contact with an Ebola-infected patient and has a high fatality 
rate. Another example of a retroviral disease with high fatality rate is the human 
immunodeficiency virus disease (HIV), which also spreads via close contact with an HIV 
infected patient (4). Since both the aforementioned diseases transmit via close contact, their rate 
of spread is slower compared to influenza.  For such diseases with lower rate of spread, sub-
exponential growth patterns would be expected (3). Further, population structure, environmental 
factors, vaccination policies, etc. also impact the spread of disease within a population. 
 
Several methods have been proposed to estimate the parameters in a model; these include least 
square estimation (LSQ) and maximum likelihood estimation (MLE) methods. The choice of 
method employed to estimate model parameters depends on the characteristics of the model and 
the available data. In this paper, both the LSQ and MLE methods are utilized to estimate model 
parameters assuming Poisson error structure like works in the previous paper (5). Previous work 
by Roosa et al., (2019) shows that LSQ with parametric bootstrapping and MLE assuming 
Poisson distribution yielded very similar results utilizing data simulated from the model (Roosa 
et al., 2019) (5). In their paper, they compare the r and p parameters of GGM and GLM for LSQ 
and MLE methods with the simulated data (5). Based on the results from their paper, for the 
purpose of our analysis we further evaluate the GGM for the LSQ and MLE methods using data 
from real disease outbreaks. We use the parametric bootstrapping method to predict the best 
guess of the initial parameters and assess the variables using the best guess of the initial 
parameters. 
 
 
2. Data and Methods 
 
2.1. Data sources 
 
Data from 25 different outbreaks are used for the purpose of this analysis. Outbreak data consists 
of  Zika (Antioqia, 2016, 30, 15 & 16 days), FMD (UK, 2001, 25 days), Ebola (Tonkolili, 2014, 
6 weeks), Cholera (Aalborg, 1853, 20 days), Ebola (Bo, 2014, 10 weeks), Ebola (Bombali, 2014, 
8 weeks), Ebola (Bomi, 2014, 8 weeks), Ebola (Congo, 1976, 20 days), Ebola (Grand Bassa, 
2014, 9 weeks), Ebola (Gueckedou, 2014, 11 weeks), Ebola (Kenema, 2014, 8 weeks), Ebola 
(Margibi, 2014, 10 & 11 weeks), Ebola ( Montserrado, 2014, 10 weeks), Ebola (Port Loko, 2014, 
8 weeks), Ebola (Uganda, 2000, 6 weeks), Ebola (Western Area Rural, 2014, 10 weeks), Ebola 
(Western Area Urban, 2014, 10 weeks), FMD (Urugay, 2001, 11 days), HIV-AIDS (Japan, 1985-
2012, 11 years), HIV-AIDS (NYC, 1982-2002, 11 years), Measles (London, 1948, 9 weeks), 
Pandemic Influenza (San Francisco, 1918, 20 days), Plague (Bombay, 1905-06, 9 weeks), Plague 
(Madagascar-wave2, 2017, 11 weeks), and Smallpox (Khulna, Bangladesh, 1972, 9 weeks) 
(Table 1-1). The temporal scale of the data varies depending on the outbreaks, with most 
outbreaks reported daily or weekly. However, the HIV-AIDS outbreaks have year as the unit of 
analysis. Therefore, in order to standardize the unit of time for our data analysis, we assume day 
as the unit of time. Hence, results depict day as our final unit of time.   
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The data is named in order disease, the place, year or period it happened and the length of 
ascending phase, or the number of data points we use. Different lengths of ascending phase are 
used for two of the outbreaks: 30, 15 and 16 data points for Zika (Antioqia, 2016) and 10 and 11 
data points for Ebola (Margibi, 2014). 
 
2.2.1. Generalized Growth Model (GGM) 
 
As we explain in the introduction, GGM allows for less than exponential growth patterns. The 
generalized growth model is composed of two parameters and one variable. The two parameters 
include the “deceleration growth parameter” p and the growth rate parameter, r.  C (t) represents 
the cumulative number of cases at time t and C΄(t) represents the incidence curve. When the 
“deceleration of growth” parameter (p) lies within the range of 0 and 1 it depicts the sub-
exponential growth patterns, p=0 shows constant/linear growth, whereas p=1 shows an 
exponential pattern. Growth rate, r parameter, is greater than 0 (6). 
 
The GGM equation is the following: 
𝑑𝐶(𝑡)
𝑑𝑡
= 𝐶΄(𝑡) = 𝑟𝐶(𝑡)𝑝 
 
Various outbreaks including Zika (7, 10), Foot and Mouth disease (8), Ebola (9), and HIV- AIDS 
(11) have been modelled using the GGM. 
 
2.3. Parameter estimation 
 
For assessing the parameters, we conduct parametric bootstrap analyses using LSQ and MLE 
methods. A previous study shows that one can evaluate parameter with a simple computational 
bootstrap-based method, by replicating several data sets through repeated sampling from the 
model. (17). When estimating parameters, the initial parameter values or “guesses” can impact 
the results due to local maxima or minima. Therefore, we utilize the bootstrap method several 
times with different initial parameter guesses to estimate the best initial parameters, or those with 
the lowest MSE, for the ‘best-fit’ model. With the initial parameters from the bootstrap method, 
we then use these values and employ the bootstrapping method to simulate 500 curves (M=500) 
from the best-fit model, and further, re-estimate the parameters for each of these new datasets. 
We then utilize the parameter estimate distributions to calculate 95% confidential intervals, root 
mean square error, prediction intervals, and Anscombe residuals.  
 
2.3.1. Least squares estimation (LSQ) 
 
The goal of the least square estimation method is to estimate the best fit line for the data. This 
method yields the best fit solution for the given time by exploring the parameters while 
minimizing the sum of the squared deviations between the data and the model solution. The 
equation is follows: 
𝜃 = 𝑎𝑟𝑔𝑚𝑖𝑛 ∑(𝑓(𝑡; 𝜃) − 𝑦𝑡)
2
𝑛
𝑡=1
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𝜃 ̂is representative of the parameters r and p employed in the GGM, yt represents the outbreaks’ 
data, and f (t; 𝜃) =C’(t|𝜃)  is the incidence cases in the GGM model. We used fmincon function 
in Matlab 2017 to get the nonlinear least squares estimation for our model parameters and restrict 
the bounds for each parameter. With this method, the overall data of the parameter has equal 
weight (13). We employ the bootstrap method to quantify the uncertainty of the parameter 
estimates. The method of LSQ with bootstrap approach is as follows: 
 
1. Estimate the best initial parameters. 
2. With the best initial parameters, fit the model to the time series data and derive 
parameter estimates with LSQ. 
3. Generate M=500 outbreaks data sets. For each data set, assume Poisson error 
distribution with mean=C’(t), which is the incidence curve for the time t.  
4. With each of the new outbreak data sets, estimate the r and p parameters with LSQ, 
prediction interval, and Anscombe residual. 
5. Based on the 500 estimated values of parameters, construct the 95% confidential 
interval and calculate the RMSE. 
 
2.3.2. Maximum likelihood estimation (MLE) 
 
The maximum likelihood estimation method estimates the parameters that maximize the 
likelihood function of the data. MLE has the same goal as LSQ in terms of estimating the 
parameters, but the primary difference between LSQ and MLE lies in the utilization of weighted 
points. LSQ puts equal weight for all data points, while MLE puts different weight for the data 
point depending on the magnitude (13, 14).  
 
The equation of the MLE estimate is: 
𝜃 = 𝑎𝑟𝑔𝑚𝑎𝑥 ∑[𝑦𝑡𝑙𝑜𝑔(𝑓(𝑡; 𝜃)) − 𝑓(𝑡; 𝜃)]
𝑛
𝑡=1
 
The method of MLE with bootstrap approach is as follows: 
 
1. Estimate the best initial parameters. 
2. With the best initial parameters, fit the model to the time series data and derive parameter 
estimates with MLE. 
3. Generate M=500 outbreaks data sets. For each data set, assume Poisson error distribution 
with mean=C’(t), which is the incidence curve for the time t.  
4. With each of the new outbreak data sets, estimate the r and p parameters with MLE, 
prediction interval, and Anscombe residual. 
5. Based on the 500 estimated values of parameters, construct the 95% confidential interval 
and calculate the RMSE. 
The variable expression is the same as with LSQ. We also employed the fmincon function in 
Matlab 2017 like LSQ. For the purpose of this research paper, we compare the results of the LSQ 
and MLE with real outbreaks. 
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2.4. Root Mean Square Error (RMSE) and Anscombe residual 
 
The residual represents the difference between the true parameter value and the distribution of 
parameter estimates. The residual shows the deviation of the model fit from the data and assesses 
the performance of the method for the model with the data (15).  One widely used metric is 
Mean square Error (MSE), along with the widely used RMSE. The equations for these are as 
follows:  
 
𝑀𝑆𝐸 =
1
𝑇
∑[𝑦𝑡 − 𝑓(𝑡; 𝜃)]
2
𝑇
𝑡=1
 
𝑅𝑀𝑆𝐸 = √
1
𝑇
∑[𝑦𝑡 − 𝑓(𝑡; 𝜃)]2
𝑇
𝑡=1
 
 
To account for individual weights of the data points, we use the Anscombe residual depicted in 
the book by McCullagh and Melder (1983) (16) which has equation as follows: 
 
𝐴𝑁𝑆𝐶𝑂𝑀𝐵𝐸 𝑅𝐸𝑆𝐼𝐷𝑈𝐴𝐿 =
3
2 [𝑦𝑡
2
3⁄ − 𝑓(𝑡; 𝜃)
2
3⁄ ]
𝑓(𝑡; 𝜃)
1
6⁄
 
𝐴𝑁𝑆𝐶𝑂𝑀𝐵𝐸 = ∑(
3
2 [𝑦𝑡 
2
3⁄ − 𝑓(𝑡; 𝜃)
2
3⁄ ]
𝑓(𝑡; 𝜃)
1
6⁄
)2
𝑇
𝑡=1
 
 
2.5. Performance 
 
From each LSQ and MLE method, estimates of parameters r and p along with 95% CI, root 
mean square error (RMSE), Anscombe and prediction coverage were calculated for the given 
outbreaks. For assessing the difference between LSQ and MLE results, we subtracted each 
variable, r and p parameters, RMSE, Anscombe, 95% prediction interval coverage, from LSQ to 
MLE (LSQ-MLE) and calculated the absolute values.  
 
 
3. Results 
 
Table 1 Result of r and p parameters with 95% CI, RMSE, Anscombe residual, prediction coverage, and the length of ascending 
phase by LSQ for each outbreak.  
 
LSQ r (95% CI) p (95% CI) RMSE Anscombe  
Prediction 
interval 
coverage 
(%) 
length of 
ascending 
phase 
Zika (Antioquia, 2016) 0.97 (0.69, 1.3) 0.57 (0.5, 0.65) 4.6547 26.1701 96.67 30 /104 days 
Zika (Antioquia, 2016) 1.6 (0.71, 2.9) 0.43 (0.24, 0.67) 3.7148 16.3014 100.00 15/104 days 
Zika (Antioquia, 2016) 1.4 (0.78, 2.3) 0.47 (0.31, 0.65) 3.3072 16.4055 100.00 16/104 days 
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FMD (UK,2001-120days) 0.56 (0.37, 0.78) 0.7 (0.6, 0.82) 3.2558 38.0777 96.00 25/229 days 
Ebola (Tonkolili, 2014) 0.19 (0.079, 0.42) 0.77 (0.51, 1) 4.7434 8.2564 83.33 6/69 weeks 
Cholera (Aalborg,1853) 0.55 (0.36, 0.8) 0.78 (0.69, 0.88) 7.8581 36.7622 90.00 20/108 days 
Ebola (Bo, 2014) 0.13 (0.083, 0.2) 0.81 (0.69, 0.94) 9.6592 27.4445 80.00 10/67 weeks 
Ebola (Bombali, 2014) 0.081 (0.064, 0.13) 0.95 (0.81, 1) 4.0774 17.0611 87.50 8/64 weeks 
Ebola (Bomi, 2014) 1.2 (0.46, 2) 0.13 (0, 0.38) 5.9372 19.6657 75.00 8/66 weeks 
Ebola (Congo, 1976) 1.3 (0.65, 2.1) 0.44 (0.28, 0.63) 3.6671 19.5928 100.00 20/52 days 
Ebola (Grand Bassa, 2014) 0.42 (0.15, 0.97) 0.34 (0.058, 0.63) 3.5119 7.6974 100.00 9/64 weeks 
Ebola (Gueckedou, 2014) 0.14 (0.04, 0.32) 0.65 (0.37, 1) 3.8494 18.0131 90.91 11/90 weeks 
Ebola (Kenema, 2014) 0.57 (0.33, 0.85) 0.47 (0.34, 0.6) 9.1378 17.5478 87.50 8/70 weeks 
Ebola (Margibi, 2014) 0.2 (0.14, 0.26) 0.75 (0.67, 0.84) 15.7639 67.8336 50.00 10/68 weeks 
Ebola (Margibi, 2014) 0.21 (0.16, 0.28) 0.72 (0.65, 0.8) 17.9671 73.2763 54.55 11/68 weeks 
Ebola (Montserrado, 2014) 0.088 (0.081, 0.11) 0.98 (0.9, 1) 9.3648 47.311 50.00 10/71 weeks 
Ebola (Port Loko, 2014) 0.57 (0.36, 0.83) 0.5 (0.4, 0.61) 8.8882 2.8635 100.00 8/64 weeks 
Ebola (Uganda, 2000) 0.34 (0.21, 0.53) 0.67 (0.52, 0.82) 5.1478 1.9795 100.00 6/18 weeks 
Ebola (Western Area Rural, 2014) 0.32 (0.22, 0.44) 0.62 (0.53, 0.71) 7.064 12.5064 90.00 10/63 weeks 
Ebola (Western Area Urban, 2014) 0.5 (0.32, 0.73) 0.53 (0.44, 0.63) 7.1063 12.1428 90.00 10/62 weeks 
FMD (Uruguay, 2001) 9.2 (7.5, 11) 0.52 (0.49, 0.55) 78.1816 163.4178 36.36 11/27 days 
HIV-AIDS (Japan, 1985-2012) 0.1 (0.097, 0.11) 0.5 (0.49, 0.51) 574.6561 784.7399 18.18 11/21 years 
HIV-AIDS (NYC, 1982-2002) 2.7 (1.6, 4.4) 0.47 (0.33, 0.6) 6.1496 22.2194 81.81 11/21 years 
Measles (London, 1948) 1.7 (1.3, 2.2) 0.51 (0.48, 0.55) 85.8138 135.7374 44.44 9/40 weeks 
Pandemic influenza (San Fran, 1918) 0.29 (0.28, 0.34) 0.99 (0.95, 1) 8.4321 57.9749 60.00 20/63 days 
Plague (Bombay, 1905-06) 0.12 (0.074, 0.17) 0.88 (0.79, 0.98) 6.5659 5.30811 100.00 9/41 weeks 
Plague (Madagascar-wave2, 2017) 0.12 (0.072, 0.18)  0.81 (0.71, 0.94) 3.451 8.1155 100.00 11/50 weeks 
Smallpox (Khulna, Bangladesh, 1972) 0.16 (0.11, 0.21) 0.85 (0.78, 0.93) 15.2023 17.3744 77.78 9/13 weeks 
 
 
Table 2 Result of r and p parameters with 95% CI, RMSE, Anscombe residual, prediction coverage, and the length of ascending 
phase by MLE for each outbreak.  
 
Outbreaks r (95% CI) p (95% CI) RMSE Anscombe  
Prediction 
interval 
coverage 
(%) 
length of 
ascending 
phase 
Zika (Antioquia, 2016) 1.1 (0.82, 1.4) 0.55 (0.48, 0.61) 4.9396 25.6333 100.00 30 /104 days 
Zika (Antioquia, 2016) 1.3 (0.75, 2.2) 0.49 (0.32, 0.65) 2.9777 15.5843 100.00 15/104 days 
Zika (Antioquia, 2016) 1.2 (0.73, 2.1) 0.51 (0.34, 0.68) 3.6486 16.0586 100.00 16/104 days 
FMD (UK,2001-120days) 0.5 (0.36, 0.67) 0.73 (0.64, 0.83) 4.005 37.2877 96.00 25/229 days 
Ebola (Tonkolili, 2014) 0.15 (0.077, 0.32) 0.82 (0.58, 1) 6.5574 8.0175 83.33 6/69 weeks 
Cholera (Aalborg,1853) 0.49 (0.34, 0.67) 0.81 (0.73, 0.89) 6.2008 36.4364 95.00 20/108 days 
Ebola (Bo, 2014) 0.13 (0.089, 0.18) 0.81 (0.71, 0.92) 9.7877 27.4529 80.00 10/67 weeks 
Ebola (Bombali, 2014) 0.075(0.063, 0.12) 0.97 (0.82, 1) 3.8406 16.0682 87.50 8/64 weeks 
Ebola (Bomi, 2014) 1.1 (0.47, 2) 0.15 (0, 0.38) 6.8829 19.6677 75.00 8/66 weeks 
Ebola (Congo, 1976) 1.1 (0.67, 1.8) 0.48, (0.32, 0.62) 3.4132 19.3494 95.00 20/52 days 
Ebola (Grand Bassa, 2014) 0.35 (0.14, 0.72) 0.4 (0.1, 0.68) 3.7712 7.4662 100.00 9/64 weeks 
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Ebola (Gueckedou, 2014) 0.12 (0.042, 0.27) 0.69 (0.4, 0.97) 4 17.9151 90.91 11/90 weeks 
Ebola (Kenema, 2014) 0.53 (0.34, 0.78) 0.49 (0.38, 0.6) 5.4314 17.3496 87.50 8/70 weeks 
Ebola (Margibi, 2014) 0.13 90.11, 0.17) 0.86 (0.79, 0.93) 21.5708 57.1537 60.00 10/68 weeks 
Ebola (Margibi, 2014) 0.15 (0.13, 0.19) 0.84 (0.75, 0.87) 16.8415 63.2808 54.55 11/68 weeks 
Ebola (Montserrado, 2014) 0.15 (0.12, 0.2) 0.8 (0.72, 0.88) 9.7005 29.4463 70.00 10/71 weeks 
Ebola (Port Loko, 2014) 0.55 (0.37, 0.8) 0.51 (0.41, 0.6) 4.8348 2.8323 100.00 8/64 weeks 
Ebola (Uganda, 2000) 0.4 (0.25, 0.59) 0.62 (0.49, 0.76) 8.1138 1.5743 100.00 6/18 weeks 
Ebola (Western Area Rural, 2014) 0.32 (0.24, 0.43) 0.62 (0.54, 0.69) 8.3666 12.5039 100.00 10/63 weeks 
Ebola (Western Area Urban, 2014) 0.53 (0.36, 0.74) 0.52 (0.44, 0.6) 6.9785 12.0879 90.00 10/62 weeks 
FMD (Uruguay, 2001) 8.2 (6.7, 9.9) 0.54 (0.51, 0.57) 62.4915 161.757 36.36 11/27 days 
HIV-AIDS (Japan, 1985-2012) 0.081 (0.076, 0.086) 0.53 (0.52, 0.53) 551.8599 725.4638 18.18 11/21 years 
HIV-AIDS (NYC, 1982-2002) 2.3 (1.4, 3.4) 0.51 (0.4, 0.63) 4.5826 21.4924 81.81 11/21 years 
Measles (London, 1948) 2.9 (2.3, 3.6) 0.44 (0.41, 0.47) 67.5681 118.335 33.33 9/40 weeks 
Pandemic influenza (San Fran, 1918) 0.35 (0.3, 0.41) 0.94 (0.91, 0.98) 14.0535 52.5996 70.00 20/63 days 
Plague (Bombay, 1905-06) 0.12 (0.085, 0.17) 0.88 (0.78, 0.98) 4.3205 4.9868 100.00 9/41 weeks 
Plague (Madagascar-wave2, 2017) 0.11 (0.073, 0.15) 0.84 (0.75, 0.93) 6.6332 7.5833 100.00 11/50 weeks 
Smallpox (Khulna, Bangladesh, 1972) 0.14 (0.11, 0.17) 0.87 (0.82, 0.93) 15.8184 16.3525 88.89 9/13 weeks 
 
 
Table 3 Difference between LSQ and MLE results. (LSQ-MLE) 
 
Difference r  p RMSE 
Abs. 
RMSE 
Anscomb
e  
Abs. 
Anscomb
e  
Predictio
n 
interval 
coverage 
(%) 
Abs. 
value of 
p_coverag
e (%) 
length of 
ascending 
phase 
Zika (Antioquia, 2016) -0.13 0.02 
-
0.2849 0.2849 0.5368 0.5368 -3.33 3.33 
30 /104 
days 
Zika (Antioquia, 2016) 0.3 
-
0.06 0.7371 0.7371 0.7171 0.7171 0.00 0.00 
15/104 
days 
Zika (Antioquia, 2016) 0.2 
-
0.04 
-
0.3414 0.3414 0.3469 0.3469 0.00 0.00 
16/104 
days 
FMD (UK,2001-120days) 0.06 
-
0.03 
-
0.7492 0.7492 0.79 0.79 0.00 0.00 
25/229 
days 
Ebola (Tonkolili, 2014) 0.04 
-
0.05 -1.814 1.814 0.2389 0.2389 0.00 0.00 6/69 weeks 
Cholera (Aalborg,1853) 0.06 
-
0.03 1.6573 1.6573 0.3258 0.3258 -5.00 5.00 
20/108 
days 
Ebola (Bo, 2014) 0 0 
-
0.1285 0.1285 -0.0084 0.0084 0.00 0.00 
10/67 
weeks 
Ebola (Bombali, 2014) 0.006 
-
0.02 0.2368 0.2368 0.9929 0.9929 0.00 0.00 8/64 weeks 
Ebola (Bomi, 2014) 0.1 
-
0.02 
-
0.9457 0.9457 -0.002 0.002 0.00 0.00 8/66 weeks 
Ebola (Congo, 1976) 0.2 
-
0.04 0.2539 0.2539 0.2434 0.2434 5.00 5.00 20/52 days 
Ebola (Grand Bassa, 2014) 0.07 
-
0.06 
-
0.2593 0.2593 0.2312 0.2312 0.00 0.00 9/64 weeks 
Ebola (Gueckedou, 2014) 0.02 
-
0.04 
-
0.1506 0.1506 0.098 0.098 0.00 0.00 
11/90 
weeks 
Ebola (Kenema, 2014) 0.04 
-
0.02 3.7064 3.7064 0.1982 0.1982 0.00 0.00 8/70 weeks 
Ebola (Margibi, 2014) 0.07 
-
0.11 
-
5.8069 5.8069 10.6799 10.6799 -10.00 10.00 
10/68 
weeks 
Ebola (Margibi, 2014) 0.06 
-
0.09 1.1256 1.1256 9.9955 9.9955 0.00 0.00 
11/68 
weeks 
12 
 
Ebola (Montserrado, 2014) 
-
0.062 0.18 
-
0.3357 0.3357 17.8647 17.8647 -20.00 20.00 
10/71 
weeks 
Ebola (Port Loko, 2014) 0.02 
-
0.01 4.0534 4.0534 0.0312 0.0312 0.00 0.00 8/64 weeks 
Ebola (Uganda, 2000) -0.06 0.05 -2.966 2.966 0.4052 0.4052 0.00 0.00 6/18 weeks 
Ebola (Western Area Rural, 2014) 0 0 
-
1.3026 1.3026 0.0025 0.0025 -10.00 10.00 
10/63 
weeks 
Ebola (Western Area Urban, 2014) -0.03 0.01 0.1278 0.1278 0.0549 0.0549 0.00 0.00 
10/62 
weeks 
FMD (Uruguay, 2001) 1 
-
0.02 
15.690
1 
15.690
1 1.6608 1.6608 0.00 0.00 11/27 days 
HIV-AIDS (Japan, 1985-2012) 0.019 
-
0.03 
22.796
2 
22.796
2 59.2761 59.2761 0.00 0.00 11/21 years 
HIV-AIDS (NYC, 1982-2002) 0.4 
-
0.04 1.567 1.567 0.727 0.727 0.00 0.00 11/21 years 
Measles (London, 1948) -1.2 0.07 
18.245
7 
18.245
7 17.4024 17.4024 11.11 11.11 9/40 weeks 
Pandemic influenza (San Fran, 
1918) -0.06 0.05 
-
5.6214 5.6214 5.3753 5.3753 -10.00 10.00 20/63 days 
Plague (Bombay, 1905-06) 0 0 2.2454 2.2454 0.32131 0.32131 0.00 0.00 9/41 weeks 
Plague (Madagascar-wave2, 2017) 0.01 
-
0.03 
-
3.1822 3.1822 0.5322 0.5322 0.00 0.00 
11/50 
weeks 
Smallpox (Khulna, Bangladesh, 
1972) 0.02 
-
0.02 
-
0.6161 0.6161 1.0219 1.0219 -11.11 11.11 9/13 weeks 
 
For each outbreak, the results with graphs including r and p parameters with 95% confidence 
interval, GGM with prediction interval, and Anscombe residual are at the appendix part (Figure 
S1-1 & S1-2). For r and p parameters, the red line represents to the mean with bootstrapping and 
red dot is 95% confidence interval. The left lower graph represents fitting the model with data. 
The blue bubble represents the data, the red line is best fit model, cyan lines represent the 500 
bootstrapping with GGM, and the red dot is for 95% prediction interval. The right lower graph is 
Anscombe residual (Appendix. Figure S1-1 & S1-2). 
 
The majority of the of 25 outbreaks that are analyzed for the purpose of this analysis had similar 
results for the growth parameter (r) (CI 95%), the deceleration parameter (p) (CI 95%), RMSE, 
Anscombe residual, and the prediction interval with LSQ and MLE methods. Growth parameter r 
and Anscombe residual have higher values for the LSQ method for most outbreaks. On the other 
hand, parameter p, shows higher value with the MLE method for most outbreaks. Values of 
RMSE and prediction coverage for the outbreaks have almost similar values with LSQ and MLE 
methods.  
   
R parameter for most outbreaks with LSQ method shows equal with or higher than than MLE 
method except 6 outbreaks, Zika (Antioquia, 2016, 30 days), Ebola (Montserrado, 2014), Ebola 
(Uganda, 2000), Ebola (Western Area Urban, 2014), Measles (London, 1948), and Pandemic 
influenza (San Fran, 1918). The range of difference r parameter with the absolute r parameter 
value is from 0 to 1.2. The outbreaks which has the most different r parameter is Measles 
(London, 1948) with 1.2, 1.7 with LSQ and 2.9 with MLE (Table 3 & Figure 1-1). 
 
The differences between LSQ and MLE for the p parameters of the outbreaks show that most 
outbreaks have higher p parameter when estimated using MLE. 9 outbreaks show that equal or 
high value when estimated using LSQ. The range of difference p parameter with the absolute p 
parameter value is from 0 to 0.18. The outbreaks which has the most different p parameter is 
Ebola (Montserrado, 2014) with 0.18, 0.98 with LSQ and 0.8 with LSQ (Table 3 & Figure 1-2).  
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RMSE and Anscombe’s residual show similar results. The range (minimum to maximum) of 
Anscombe’s residual with the LSQ method is observed to be between 3.2558 for Foot and Mouth 
Disease (UK, 2001) and 574.6561 for HIV-AIDS epidemic (Japan, 1985-2012) .Whereas, the 
range of RMSE with the MLE method is between 2.9777 (as observed for the Zika epidemic 
(Antioquia, 2016) with 15 data points) and 551.8599 (as observed with the HIV-AIDS epidemic 
(Japan, 1985-2012)). The range of the difference between two methods of the RMSE is between 
0.1506 and 22.7962. The lowest difference value is Ebola (Gueckedou, 2014), and the highest 
difference value is HIV-AIDS (Japan, 1985-2012). 13 out of 28 outbreaks have higher RMSE for 
LSQ compared to MLE. 
 
For the Anscombe residual, we observe a broad range of values for the outbreaks, ranging 
between 1.9795 and 784.7399 with LSQ method and between 1.5743 and 725.4638 with MLE. 
However, the difference of the Anscombe residual for the two methods ranges between 0.002 
and 59.2761. The lowest difference value for the Anscombe residual is observed for the Ebola 
outbreak (Bomi, 2014) and the highest difference is observed for the HIV-AIDS outbreak (Japan, 
1985-2012). For the majority of the outbreaks analyzed, the Anscombe residual estimated by the  
MLE method is lower than the Anscombe residual for the LSQ method, with the exception of 
two outbreaks where the Anscombe residual estimated by the LSQ  method is lower than that 
estimated by the MLE method (Ebola (Bo, 2014) and Ebola (Bomi, 2014)). 
 
Prediction interval coverage for most outbreaks with LSQ method show over 80% coverage, 
excluding 75% for Ebola (Bomi, 2014), 50% and 54.55% for Ebola (Margibi, 2014) using 10 
and 11 data points respectively, 50% for Ebola (Montserrado, 2014), 36.36% for FMD (Uruguay, 
2001), 44.44% for measles (London, 1948), 60% for Pandemic influenza (San Fransisco, 1918), 
and 77.78% for smallpox (Khulna, Bangladesh, 1972).  Most values of the prediction inverval 
coverage with MLE method also show a prediction coverage of over 80%, excluding 75% 
coverage for Ebola (Bomi, 2014), 60% and 54.55% for Ebola (Margibi, 2014) for 10 and 11 data 
points respectively, 70% for Ebola (Montserrado, 2014), 36.36% for FMD (Uruguay, 2001), 
18.18% for HIV-AIDS (Japan, 1985-2012), and 33.33% for measles (London, 1948). Between 
the two methods, we observe a difference of less than 5 % for the prediction coverage for most 
outbreaks. However,  approximately 6 outbreaks have more than 5% difference in the prediction 
coverage between the two methods, and these include a 10% difference in the prediction 
coverage of two methods for the Ebola  outbreak (Margibi, 2014) using 10 data points, 20% 
difference in the Ebola (Montserrado, 2014), 10% difference in the Ebola (Western Area, Rural, 
2014), 11.11% difference in the measles (London, 1948), a 10% difference in the pandemic 
influenza (San Francisco, 1918), and an 11.11% difference in the smallpox (Khulna Bangladesh, 
1972). 
 
For the 95% prediction coverage, most of the outbreaks show the same coverage when estimated 
using LSQ and MLE methods. However, 9 outbreaks show a difference in the estimated values 
of 95% prediction coverage between the two methods. Among these 9 outbreaks, 7 outbreaks 
have a higher 95% prediction coverage when estimated using the MLE method compared to the 
coverage for the LSQ method. The most deviant result is observed for the Ebola (Montserrado, 
2014) outbreak with a difference of 20% in the prediction coverage with 50% when estimated 
using LSQ method and 70% when estimated using MLE method. 
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Among 25 outbreaks, 14 outbreaks are Ebola. Among the Ebola outbreaks, the growth 
parameter, r, ranges from 0.08 for the LSQ (Ebola (Bombali, 2014)) to 1.3 (Ebola (Congo, 
1976)), and for the MLE method the growth parameter ranges from 0.08 (Ebola (Bombali, 
2014)) to 1.1 (Ebola (Bomi, 2014) and Ebola (Congo, 1976)). The difference between the range 
of the two methods is between 0 (Ebola (Bombali, 2014) and Ebola (Western Area Rural, 2014)), 
0.2 (Ebola (Congco, 1976)). P parameter’s range for LSQ method is between 0.13 (Ebola (Bomi, 
2014)) and 0.98 (Ebola (Montserrado, 2014)); whereas, for the MLE method the range of p 
parameter is between 0.15 (Ebola (Bomi, 2014)) and 0.97 (Ebola (Bombali, 2014)). The 
difference between the range of the two methods is between 0 (Ebola (Bo, 2014), Ebola 
(Western Area, Rural, 2014)) and 0.18 (Ebola (Montserrado, 2014)).  
 
Figure1-1 Parameter error bars. For each outbreak, the graphs show the mean and 95% confidential interval of r for LSQ and 
MLE methods. 
 
15 
 
Figure1-2 Parameter error bars. For each outbreak, the graphs show the mean and 95% confidential interval of p for LSQ and 
MLE methods.
 
4. Discussion 
 
Among the 28 outbreaks analyzed, the mean value for r shows similar results for the LSQ and 
MLE methods for most outbreaks (Figure 1-1). All but six outbreaks have higher mean estimates 
of r using the LSQ method in comparison to use the MLE method, but the differences are small 
(Table 3). A marked difference in the absolute value for r parameter estimates by the LSQ and 
MLE method is observed for the Measles outbreak (London, 1948), 1.2. Except 2 outbreaks, 
Measles (London, 1948) and FMD (Uruguay, 2001), the rest outbreaks show less than 1 for the r 
parameter difference between LSQ and MLE. With the result, both LSQ and MLE product the 
similar results for r parameter estimation. 
 
20 of the total 28 outbreaks have higher estimated values of p with the LSQ method. However, 
the highest differing value of the p parameter is found to be 0.18 for the Ebola epidemic 
(Montserrado, 2014) with 0.98 for LSQ and 0.8 for MLE (Table 1,2, &3). This value is close to 0 
but it is not a similar value regarding with the range of the p parameter, which was identified to 
be from 0 to 1. 26 of the outbreaks have an absolute mean difference less than 0.1 for the 
estimated parameter p value (Figure 1-2 & Table 3). Except 2 outbreaks, Ebola outbreak 
(Margibi, 2014, 10 weeks) and Ebola outbreaks (Montserrado, 2014), the rest outbreaks show 
less than 0.1 for the p parameter difference between LSQ and MLE. With the result, both LSQ 
and MLE product the similar results for p parameter estimation like r parameter result. 
 
As mentioned at method part, RMSE and Anscombe residual indicate goodness-of-fit for the best 
fit model with the data with the estimated parameters. Of the total outbreaks, 15 show the value 
of RMSE to be higher with the LSQ method compared to the MLE method, though for all but 3 
outbreaks, the absolute difference in RMSE values is observed to be lower than 10. LSQ has 
higher RMSE values for 15 outbreaks, indicating that MLE provided a better fit to the data. The 
absolute values of the RMSE come out to be less than 1 for half of the outbreaks, which 
concludes that LSQ and MLE methods perform comparably in terms of RMSE.  The most 
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different result for RMSE between LSQ and MLE is estimated for the HIV-AIDS (Japan, 1985-
2012). It ranges from 574.6561 for the LSQ method and 551.8599 for the MLE method, though 
this higher difference is expected with the high values of the RMSE for LSQ and MLE 
respectively. But the differences for the most outbreaks are small, indicating that the result of 
RMSE for two methods are similar.  
 
For all but two outbreaks, MLE yielded higher values of Anscombe compared to LSQ. The 
highest difference is observed for the HIV-AIDS epidemic (Japan, 1985-2012), 59.2761. Most 
outbreaks show a difference of less than 10 for the Anscombe residual when estimated using 
LSQ versus MLE methods. Like RMSE, Anscombe residual indicates that lower value shows a 
better fit to the data. With the indication, for most outbreaks, using MLE provides better fit to the 
data. But the differences between two methods are small for most outbreaks, indicating that 
Anscombe residuals are similar with two methods.   
 
Even Anscombe residual would be better for the Poisson distribution, both RMSE and 
Anscombe residual assess the goodness of fit, so the result tendency would show similar. For 
example, the outbreak that has the most different value is HIV-AIDS epidemic (Japan, 1985-
2012). However, this result also indicates that GGM would not a good model for this outbreak 
since the HIV at Japan outbreak and Measles outbreaks at London have very high values for both 
variables respectively.   
 
For the 95% prediction interval coverage, most outbreaks show similar results between LSQ and 
MLE. The prediction interval coverage shows how the GGM fit with the data. Even though the 
difference in the prediction interval estimates using LSQ and MLE methods for Ebola 
(Monteserrado, 2014) is smaller than that for the Pandemic Influenza (San Francisco, 1918), the 
number of data point terms seems different. The total of data points used for the analysis of 
Ebola (Montserrado, 2014) is 10 and those used for the analysis of Pandemic Influenza (San 
Francisco, 1918) were 20. Therefore, the prediction coverage percentage for the Pandemic 
Influenza (San Francisco, 1918) is estimated to be lower than for the Ebola (Montserrado, 2014) 
epidemic. 
 
For some outbreaks, the 95% prediction interval coverages are low; however, the different result 
show that there is not different since 95% prediction interval coverage for both methods are 
same. For example, HIV-ADIS (Japan, 1985-2012) has 18.18% for LSQ and MLE methods. 
Even though the coverages are low for each method, the result shows that there is no different. In 
terms of the RMSE and Anscombe residual, some outbreaks have high values; for example, 
HIV-ADIS (Japan, 1985-2012) has around 550 RMSE and around 700 Anscombe residual for 
both methods, which mean the model is not fit with the data. 
 
The result would not adapt to the other model such as generalized logistic growth model (LGM) 
since this study is used for GGM and estimate just r and p parameters. Further, in terms of the 
ascending phase, two outbreaks, Zika (Antioquia, 2016) and Ebola (Margibi, 2014) are used with 
different data points. Just Zika (Antioquia, 2016) with 30 days from with 15 and 16 days has 
different results of r and p parameters, RMSE, Anscombe residual and prediction interval 
coverage with LSQ method and p parameter, RMSE, and Anscombe residual with MLE method. 
But it is hard to say that the ascending phase affect the results of the methods comparably since it 
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was one outbreak. Future studies could include comparing the parameter estimation with other 
models and the effect of the ascending phase into the results. 
 
Overall, results demonstrate that utilizing LSQ and MLE methods deduct similar results for the 
GGM parameters r and p, RMSE, Anscombe residual, and prediction coverage for most 
outbreaks despite showing a large difference for a few. It is also demonstrated that the number of 
data points effect the results; however, we do not have enough information on how to calculate 
the exact number of data points required. 
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FigrueS1-1. GGM parameter estimates as each outbreak. Parameters r and p estimates and 95% 
confidence intervals are represented at upper two graphs. For the r and p parameters graphs, the red line 
means mean of the results and red dash as the 95% CI of the results. Left below figure shows the fitting 
GGM model with blue bubbles as the data, red dash line as 95% prediction interval, red line as mean of 
bootstrap, grey lines as bootstraps, and cyan as prediction intervals bootstraps 
a-1. Zika (Antioquia, 2016, (30d) with LSQ method  
 
a-2. Zika (Antioquia, 2016, 30d) with MLE method  
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b-1 Zika (Antioquia, 2016, 16d) with LSQ method
 
b-2 Zika (Antioquia, 2016, 16d) with MLE method 
 
c-1 Zika (Antioquia, 2016, 15d) with LSQ method 
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c-2 Zika (Antioquia, 2016, 15d) with MLE method 
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d-1 FMD (UK,2001-120days, 25d) with LSQ method
 
d-2 FMD (UK,2001-120days, 25d) with MLE method 
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e-1 Ebola (Tonkolili, 2014, 6w) with LSQ method
 
e-2 Ebola (Tonkolili, 2014, 6w) with MLE method 
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f-1 Cholera (Aalborg,1853, 20d) with LSQ method
 
f-2 Cholera (Aalborg, 1853, 20d) with MLE method 
 
g-1 Ebola (Bo, 2014) with LSQ method 
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g-2 Ebola (Bo, 2014) with MLE method 
 
 
h-1 Ebola (Bombali, 2014) (8w) with LSQ method 
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h-1 Ebola (Bombali, 2014) (8w) with MLE method 
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i-1 Ebola (Bomi, 2014) (8w) with LSQ method
 
i- 2 Ebola (Bomi, 2014) (8w) with MLE method 
 
x 
 
j-1 Ebola (Congo, 1976) (20d) with LSQ method
 
j-2 Ebola (Congo, 1976) (20d) with MLE method 
 
k-1 Ebola (Grand Bassa, 2014) wih LSQ method 
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k-2 Ebola (Grand Bassa, 2014) wih MLE method 
 
 
l-1 Ebola (Gueckedou, 2014) (11w) with LSQ method 
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l-2 Ebola (Gueckedou, 2014) (11w) with MLE method 
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m-1 Ebola (Kenema, 2014) (8w) with LSQ method
 
m-2 Ebola (Kenema, 2014) (8w) with MLE method 
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n-1 Ebola (Margibi, 2014) (11w) with LSQ method
 
n-2 Ebola (Margibi, 2014) (11w) with MLE method 
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Figrue1-2. GGM parameter estimates as each outbreaks (cont.) Parameters r and p estimates and 95% 
confidence intervals are represented at upper two graphs and left below figure shows the fitting GGM 
model with blue bubbles as the data, red dash line as 95% prediction interval, red line as mean of 
bootstrap, grey lines as bootstraps, and cyan as prediction intervals bootstraps 
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